Last updated on February 2020

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis


Brief description of study

This multicenter study is being conducted to provide additional PF-06826647 safety and tolerability data, and to further explore the clinical efficacy of PF-06826647 in the treatment of moderate to severe plaque psoriasis. Additionally, the study is intended to enable selection of oral dose and dosing regimen for the future clinical development of PF-06826647.

Clinical Study Identifier: NCT03895372

Find a site near you

Start Over

Renstar Medical Research

Ocala, FL United States
  Connect »

MidState Skin Institute

Ocala, FL United States
  Connect »

Advanced Diagnostic Group

Orange Park, FL United States
  Connect »

Park Avenue Dermatology

Orange Park, FL United States
  Connect »

DelRicht Research

Baton Rouge, LA United States
  Connect »

Kern Allergy and Medical Research

Bakersfield, CA United States
  Connect »

Ameriderm Research

Ormond Beach, FL United States
  Connect »

Anaheim Clinical Trials

Anaheim, CA United States
  Connect »

Dynamic Medical Imaging

Anaheim, CA United States
  Connect »

Medderm Associates Dermatology

San Diego, CA United States
  Connect »

University Clinical Trials

San Diego, CA United States
  Connect »

Hamilton Research, LLC

Alpharetta, GA United States
  Connect »

Kansas City Dermatology, P.A.

Overland Park, KS United States
  Connect »

Qualmedica Research, LLC

Owensboro, KY United States
  Connect »

Skin Specialists PC

Omaha, NE United States
  Connect »

SKiN Health

Cobourg, ON Canada
  Connect »

First OC Dermatology

Fountain Valley, CA United States
  Connect »

Austin Radiological Association

Round Rock, TX United States
  Connect »